Europe's first stem cell trials set to start

 

Lewis Smith
Friday 23 September 2011 00:00
Comments

A radical new medical procedure designed to halt the damage caused by a degenerative eye disease is to be tested in Europe's first clinical trial using embryonic stem cells.

Twelve volunteer patients suffering from Stargardt's macular dystrophy, which is incurable and develops in childhood, will have cells injected directly into their eyes to test the procedure.

If successful, the treatment will not just open up a wide range of possible treatments for eye diseases, but would be a huge boost for medicine because embryonic stem cells are thought to hold the key to tackling many types of disease.

Embryonic stem cells are regarded as "master cells" which have the potential to be develop into many different cell types.

The trial was announced by Moorfields Eye Hospital and will be led by Professor James Bainbridge, who said: "This is the first time embryonic stem cells have been used here. They have great potential to be able to regenerate a variety of different tissues and organs. It's very exciting now to be at the stage where we can begin to explore that potential."

If they are as successful as researchers hope, a treatment based on the trials could be available in five to 10 years.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in